Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
University Health Network · Memorial Sloan Kettering Cancer Center · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
247
total citations
- FWCI
- 56.95
- Percentile
- 100%
- References
- 37
Citations per year
Authors
75- CJC. Jillian TsaiCorresponding
University Health Network, Memorial Sloan Kettering Cancer Center, Princess Margaret Cancer Centre
- JTJonathan T. Yang
University of Washington
- NSNarek Shaverdian
Memorial Sloan Kettering Cancer Center
- JPJuber Patel
Memorial Sloan Kettering Cancer Center
- AFAnnemarie F. Shepherd
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- Radiation therapy
- Medicine
- Cancer
- Breast cancer
- Lung cancer
- Standard of care
- Stereotactic radiotherapy
- Systemic therapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.